Genomic screening for newborns and children to identify genetic disorders early
Age-based genomic screening in newborns, infants, and children: a novel paradigm in public health genomics
This study is exploring a new way to check children's genes during their regular check-ups to help parents find out about any genetic conditions early on, so they can take action to keep their kids healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10877822 on NIH RePORTER |
What this research studies
This research investigates a new approach to genomic screening based on the age of children, aiming to provide parents with actionable genetic information during routine wellness visits. By focusing on specific time-points in infancy and childhood, the study seeks to identify genetic conditions that can be addressed early to prevent or reduce symptoms. The project involves collaboration with experts and community stakeholders to ensure the screening process is effective and accessible. It also aims to understand and overcome barriers to implementing this screening in public health settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are newborns, infants, and children up to 11 years old who are undergoing routine health check-ups.
Not a fit: Patients who are adults or those who do not have children may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and intervention for genetic disorders in children, improving health outcomes.
How similar studies have performed: Other research has shown promise in age-based genomic screening approaches, indicating potential for success in this novel paradigm.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Berg, Jonathan S — Univ of North Carolina Chapel Hill
- Study coordinator: Berg, Jonathan S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.